Status:
COMPLETED
Improving Adherence to Oral Antipsychotic Medications in People With Schizophrenia
Lead Sponsor:
The University of Texas Health Science Center at San Antonio
Conditions:
Schizophrenia
Schizoaffective Disorder
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
This study will determine the comparative effectiveness of two systems designed to improve medication adherence in people with schizophrenia.
Detailed Description
Schizophrenia is a severely debilitating mental disorder. People with schizophrenia often experience unusual thoughts or perceptions, decreased pleasure in everyday life, and difficulty functioning in...
Eligibility Criteria
Inclusion
- Diagnosis of schizophrenia or schizoaffective disorder according to DSM-IV criteria, as determined on the basis of the Structured Clinical Interview for Diagnosis (SCID-P)
- Receiving treatment with an oral atypical antipsychotic medication other than clozapine (e.g., risperidone, olanzapine, quetiapine, aripiprazole, ziprasidone, or others as they are FDA approved)
- Assumes some responsibility for taking own medications
- Able to provide evidence of a stable living environment (e.g., individual apartment, family home, or board and care facility) within 3 months prior to study entry and no plans to move in the next year
- Intact visual and auditory ability as determined by a computerized screening battery
- Ability to read at the 5th grade level or higher based upon score on the Wide Range Achievement Test (WRAT)
- Able to understand and complete rating scales and neuropsychological testing
- Working telephone present in the home
Exclusion
- History of significant head trauma, seizure disorder, or mental retardation
- Alcohol or drug abuse or dependence within 3 months prior to study entry
- Currently being treated by an assertive community treatment (ACT) team
- History of violence within 1 year prior to study entry
- Any hospitalizations within 3 months prior to study entry
Key Trial Info
Start Date :
November 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2013
Estimated Enrollment :
197 Patients enrolled
Trial Details
Trial ID
NCT00406718
Start Date
November 1 2006
End Date
July 1 2013
Last Update
October 5 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of Texas Health Science Center at San Antonio
San Antonio, Texas, United States, 78207